Bull
$24.00
情景价格
$11.850
-0.148 (-1.25%)收盘时
Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world.
Cellebrite DI Ltd is currently not a strong buy due to its recent performance and lowered guidance. The current price is $11.99, which is significantly below the analyst price target of $22 from DA Davidson, indicating potential upside. However, the company has faced challenges, including a 29.18% drop in stock price following a revenue guidance cut, which is a major risk. Additionally, the RSI is at 49.83, suggesting the stock is neither overbought nor oversold, indicating a wait-and-see approach may be prudent.
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Cellebrite's Subsidiary Achieves CMMC Level 2 Certification

Cellebrite Achieves CMMC Level 2 Certification for Federal Solutions

Cellebrite Launches Tactical Extraction Kit for Military Use

Cellebrite Launches Tactical Extraction Kit for Military Use

Cellebrite Launches Tactical Extraction Kit for Military Use
Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. It operates in the Technology sector.
Cellebrite DI Ltd is currently not a strong buy due to its recent performance and lowered guidance. The current price is $11.99, which is significantly below the analyst price target of $22 from DA Davidson, indicating potential upside. However, the company has faced challenges, including a 29.18% drop in stock price following a revenue guidance cut, which is a major risk. Additionally, the RSI is at 49.83, suggesting the stock is neither overbought nor oversold, indicating a wait-and-see approach may be prudent.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。